Acro Biomedical (ACBM) Asset Utilization Ratio (2018 - 2023)

Acro Biomedical's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 1.29 for Q3 2023.

• In Q3 2023, Asset Utilization Ratio fell 5.54% year-over-year to 1.29; the TTM figure through Sep 2023 stood at 1.29 (down 5.54% YoY), while the FY2022 annual figure was 0.91, down 33.22% from the prior year.
• Asset Utilization Ratio was 1.29 for Q3 2023 at Acro Biomedical, up from 0.6 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 4.94 in Q1 2019 to a low of 0.54 in Q1 2023.
• Historically, Asset Utilization Ratio has averaged 1.45 across 5 years, with a median of 0.99 in 2022.
• The sharpest annual moves came in 2020 and 2022: Asset Utilization Ratio plunged 81.73% in 2020, then jumped 130.59% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 1.55 in 2019, then slumped by 42.63% to 0.89 in 2020, then surged by 94.11% to 1.72 in 2021, then tumbled by 42.54% to 0.99 in 2022, then surged by 30.38% to 1.29 in 2023.
• The last three Asset Utilization Ratio figures came in at 1.29 (Q3 2023), 0.6 (Q2 2023), and 0.54 (Q1 2023), per Business Quant data.